The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.
<h4>Background</h4>Dihydroartemisinin-piperaquine (DP) is increasingly recommended for antimalarial treatment in many endemic countries; however, concerns have been raised over its potential under dosing in young children. We investigated the influence of different dosing schedules on DP...
Guardado en:
Autor principal: | WorldWide Antimalarial Resistance Network (WWARN) DP Study Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/129203c2912c4b8aa4e973b841098616 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
por: Erika Wallender, et al.
Publicado: (2021) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Palang Chotsiri, et al.
Publicado: (2019) -
Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania
por: Karol J. Marwa, et al.
Publicado: (2021) -
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Leila S. Ross, et al.
Publicado: (2018) -
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial.
por: Thandile Nkosi-Gondwe, et al.
Publicado: (2021)